Episode 6
6: Episode 6: Approval of Oral Semaglutide and PIONEER Trials with Dr. Aroda
September 23, 20199m 32s
Audio is streamed directly from the publisher (audioboom.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The approval of oral semaglutide, an oral GLP-1 receptor agonist, could mark the beginning of a new era in the treatment of diabetes. We sat down with PIONEER investigator Vanita Aroda, MD, of Brigham and Women's, to learn more about the impact of this approval.